questionsmedicales.fr
Cellules
Neurones
Neurofibres
Neurofibres : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres : Questions médicales les plus fréquentes",
"headline": "Neurofibres : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-06",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurones",
"url": "https://questionsmedicales.fr/mesh/D009474",
"about": {
"@type": "MedicalCondition",
"name": "Neurones",
"code": {
"@type": "MedicalCode",
"code": "D009474",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres adrénergiques",
"alternateName": "Adrenergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D000320",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres adrénergiques",
"code": {
"@type": "MedicalCode",
"code": "D000320",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.075"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes postganglionnaires",
"alternateName": "Autonomic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D001338",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001338",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres sympathiques postganglionnaires",
"alternateName": "Sympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017779",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres sympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017779",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.100.800"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Axones",
"alternateName": "Axons",
"url": "https://questionsmedicales.fr/mesh/D001369",
"about": {
"@type": "MedicalCondition",
"name": "Axones",
"code": {
"@type": "MedicalCode",
"code": "D001369",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Segment initial de l'axone",
"alternateName": "Axon Initial Segment",
"url": "https://questionsmedicales.fr/mesh/D000071040",
"about": {
"@type": "MedicalCondition",
"name": "Segment initial de l'axone",
"code": {
"@type": "MedicalCode",
"code": "D000071040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.250"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cônes de croissance",
"alternateName": "Growth Cones",
"url": "https://questionsmedicales.fr/mesh/D020439",
"about": {
"@type": "MedicalCondition",
"name": "Cônes de croissance",
"code": {
"@type": "MedicalCode",
"code": "D020439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.375"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Fibres moussues de l'hippocampe",
"alternateName": "Mossy Fibers, Hippocampal",
"url": "https://questionsmedicales.fr/mesh/D019599",
"about": {
"@type": "MedicalCondition",
"name": "Fibres moussues de l'hippocampe",
"code": {
"@type": "MedicalCode",
"code": "D019599",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.438"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Terminaisons présynaptiques",
"alternateName": "Presynaptic Terminals",
"url": "https://questionsmedicales.fr/mesh/D017729",
"about": {
"@type": "MedicalCondition",
"name": "Terminaisons présynaptiques",
"code": {
"@type": "MedicalCode",
"code": "D017729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Collatéraux de Schaffer",
"alternateName": "Schaffer Collaterals",
"url": "https://questionsmedicales.fr/mesh/D000094282",
"about": {
"@type": "MedicalCondition",
"name": "Collatéraux de Schaffer",
"code": {
"@type": "MedicalCode",
"code": "D000094282",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.145.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres cholinergiques",
"alternateName": "Cholinergic Fibers",
"url": "https://questionsmedicales.fr/mesh/D002799",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres cholinergiques",
"code": {
"@type": "MedicalCode",
"code": "D002799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres autonomes préganglionnaires",
"alternateName": "Autonomic Fibers, Preganglionic",
"url": "https://questionsmedicales.fr/mesh/D001339",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres autonomes préganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D001339",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres parasympathiques postganglionnaires",
"alternateName": "Parasympathetic Fibers, Postganglionic",
"url": "https://questionsmedicales.fr/mesh/D017777",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres parasympathiques postganglionnaires",
"code": {
"@type": "MedicalCode",
"code": "D017777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.234.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Gaine de myéline",
"alternateName": "Myelin Sheath",
"url": "https://questionsmedicales.fr/mesh/D009186",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de myéline",
"code": {
"@type": "MedicalCode",
"code": "D009186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Gaine de Schwann",
"alternateName": "Neurilemma",
"url": "https://questionsmedicales.fr/mesh/D009441",
"about": {
"@type": "MedicalCondition",
"name": "Gaine de Schwann",
"code": {
"@type": "MedicalCode",
"code": "D009441",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Noeuds de Ranvier",
"alternateName": "Ranvier's Nodes",
"url": "https://questionsmedicales.fr/mesh/D011901",
"about": {
"@type": "MedicalCondition",
"name": "Noeuds de Ranvier",
"code": {
"@type": "MedicalCode",
"code": "D011901",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.512.560.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Neurofibres non-myélinisées",
"alternateName": "Nerve Fibers, Unmyelinated",
"url": "https://questionsmedicales.fr/mesh/D036421",
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres non-myélinisées",
"code": {
"@type": "MedicalCode",
"code": "D036421",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671.501.756"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres",
"alternateName": "Nerve Fibers",
"code": {
"@type": "MedicalCode",
"code": "D009412",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Z V Surnina",
"url": "https://questionsmedicales.fr/author/Z%20V%20Surnina",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "S E Avetisov",
"url": "https://questionsmedicales.fr/author/S%20E%20Avetisov",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Yao-Chuan Chang",
"url": "https://questionsmedicales.fr/author/Yao-Chuan%20Chang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA."
}
},
{
"@type": "Person",
"name": "Stavros Zanos",
"url": "https://questionsmedicales.fr/author/Stavros%20Zanos",
"affiliation": {
"@type": "Organization",
"name": "Institute of Bioelectronic Medicine, Feinstein Institutes for Medical Research, Manhasset, NY, 11030, USA. Electronic address: szanos@northwell.edu."
}
},
{
"@type": "Person",
"name": "Elçin Tunçkol",
"url": "https://questionsmedicales.fr/author/El%C3%A7in%20Tun%C3%A7kol",
"affiliation": {
"@type": "Organization",
"name": "Bernstein Center for Computational Neuroscience Berlin, Humboldt-Universität zu Berlin, Philippstrasse 13, Haus 6, Berlin, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension.",
"datePublished": "2022-11-03",
"url": "https://questionsmedicales.fr/article/36326841",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00392-022-02120-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effectiveness of different treatments for odontogenic keratocyst: a network meta-analysis.",
"datePublished": "2022-09-21",
"url": "https://questionsmedicales.fr/article/36150944",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijom.2022.09.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Herbal Medicines for Rhinosinusitis: A Systematic Review and Network Meta-analysis.",
"datePublished": "2023-01-07",
"url": "https://questionsmedicales.fr/article/36609950",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11882-022-01060-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis.",
"datePublished": "2022-07-15",
"url": "https://questionsmedicales.fr/article/35840702",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-16146-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Theory and practice of Bayesian and frequentist frameworks for network meta-analysis.",
"datePublished": "2022-06-27",
"url": "https://questionsmedicales.fr/article/35760451",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjebm-2022-111928"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres",
"item": "https://questionsmedicales.fr/mesh/D009412"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres",
"description": "Comment diagnostiquer une neuropathie ?\nQuels tests pour évaluer les neurofibres ?\nLes IRM sont-elles utiles pour les neurofibres ?\nQuels signes indiquent une atteinte des neurofibres ?\nComment évaluer la conduction nerveuse ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres",
"description": "Quels sont les symptômes d'une neuropathie ?\nComment se manifeste une neuropathie périphérique ?\nLes symptômes varient-ils selon le type de neurofibres ?\nPeut-on avoir des symptômes sans lésions visibles ?\nLes symptômes s'aggravent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres",
"description": "Comment prévenir les neuropathies ?\nL'exercice régulier aide-t-il à prévenir les neuropathies ?\nLes habitudes alimentaires influencent-elles les neurofibres ?\nFumer augmente-t-il le risque de neuropathie ?\nLe stress a-t-il un impact sur les neurofibres ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres",
"description": "Quels traitements existent pour les neuropathies ?\nLes médicaments peuvent-ils soulager la douleur nerveuse ?\nLa physiothérapie aide-t-elle les patients ?\nQuand envisager une intervention chirurgicale ?\nLes traitements sont-ils efficaces pour tous ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres",
"description": "Quelles complications peuvent survenir avec une neuropathie ?\nLa neuropathie peut-elle entraîner des amputations ?\nLes troubles de la marche sont-ils une complication ?\nPeut-on développer une dépression à cause de la neuropathie ?\nLes complications sont-elles réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres",
"description": "Quels sont les principaux facteurs de risque de neuropathie ?\nL'âge influence-t-il le risque de neuropathie ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe diabète est-il un facteur de risque majeur ?\nLes carences nutritionnelles augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009412?mesh_terms=Network+Meta-Analysis&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une neuropathie ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un examen neurologique, des tests électrophysiologiques et des analyses sanguines sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les neurofibres ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électromyographie (EMG) et les potentiels évoqués sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les IRM sont-elles utiles pour les neurofibres ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les IRM peuvent visualiser les lésions nerveuses et les anomalies des neurofibres."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une atteinte des neurofibres ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des engourdissements ou une faiblesse musculaire peuvent indiquer une atteinte."
}
},
{
"@type": "Question",
"name": "Comment évaluer la conduction nerveuse ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de conduction nerveuse mesurent la vitesse des signaux dans les neurofibres."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une neuropathie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleur, picotements, faiblesse musculaire et perte de sensation."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une neuropathie périphérique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des douleurs, des engourdissements et des réflexes diminués."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de neurofibres ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes dépendent du type de neurofibres affectées (sensitives, motrices)."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans lésions visibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent survenir sans lésions visibles sur les examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Les symptômes s'aggravent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, les symptômes peuvent s'aggraver progressivement sans traitement."
}
},
{
"@type": "Question",
"name": "Comment prévenir les neuropathies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain, contrôler le diabète et éviter les toxines peuvent aider."
}
},
{
"@type": "Question",
"name": "L'exercice régulier aide-t-il à prévenir les neuropathies ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier améliore la circulation sanguine et la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles les neurofibres ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en vitamines B peut soutenir la santé nerveuse."
}
},
{
"@type": "Question",
"name": "Fumer augmente-t-il le risque de neuropathie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut endommager les vaisseaux sanguins et affecter les nerfs."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les neurofibres ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut exacerber les symptômes nerveux et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les neuropathies ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent médicaments, thérapies physiques et interventions chirurgicales."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager la douleur nerveuse ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits pour soulager la douleur."
}
},
{
"@type": "Question",
"name": "La physiothérapie aide-t-elle les patients ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Quand envisager une intervention chirurgicale ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une chirurgie est envisagée si les symptômes sont graves et ne répondent pas aux traitements conservateurs."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils efficaces pour tous ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité des traitements varie selon la cause et la gravité de la neuropathie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une neuropathie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections, des blessures et des problèmes d'équilibre."
}
},
{
"@type": "Question",
"name": "La neuropathie peut-elle entraîner des amputations ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des lésions nerveuses sévères peuvent augmenter le risque d'amputation, surtout chez les diabétiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la marche sont-ils une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la neuropathie peut affecter la coordination et entraîner des troubles de la marche."
}
},
{
"@type": "Question",
"name": "Peut-on développer une dépression à cause de la neuropathie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique et les limitations fonctionnelles peuvent contribuer à la dépression."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque de neuropathie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et certaines maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de neuropathie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de neuropathie augmente avec l'âge en raison de la dégradation nerveuse."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de neuropathie peuvent augmenter le risque individuel."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque majeur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète est l'un des principaux facteurs de risque de neuropathie périphérique."
}
},
{
"@type": "Question",
"name": "Les carences nutritionnelles augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des carences en vitamines B et en acide folique peuvent augmenter le risque de neuropathie."
}
}
]
}
]
}
Sacubitril/valsartan has been demonstrated to reduce blood pressure in hypertensive patients, but the best dose remains unclear. We performed this network meta-analysis to determine the comparative ef...
We searched four databases for relevant studies published before January 2022. Mean systolic and diastolic blood pressures in the sitting position (msSBP and msDBP) and ambulatory condition (24-h maSB...
In hypertensive patients, 200 mg once daily of sacubitril/valsartan may exert a greater reduction in ambulatory blood pressure than 100 mg once daily and 200 mg once daily may not be inferior to 400 m...
Odontogenic keratocysts (OKC) are benign but aggressive lesions. As there is a lack of well randomized clinical studies assessing the effectiveness of the different treatment options for OKC, a networ...
To analyze and compare the effects of herbal medicines (HMs) for treating different forms of rhinosinusitis....
Forty-seven randomized controlled trials evaluating 18 HMs in six different rhinosinusitis populations were included in the network meta-analysis. Certainty of evidence was assessed using the Grading ...
PROSPERO ID: CRD42022328265 May 10, 2022....
Several studies investigated the effectiveness and the safety of different doses of pregabalin in fibromyalgia. However, the optimal protocol remains controversial. A Bayesian network meta-analysis co...
Network meta-analysis (NMA) is an increasingly popular statistical method of synthesising evidence to assess the comparative benefits and harms of multiple treatments in a single analysis. Several aut...
There are limited pooled data showing the impact of visceral metastasis on oncologic outcomes in metastatic prostate cancer patients treated with combination systemic therapies. We aimed to analyze an...
Three databases were queried in July 2022 for randomized, controlled trials analyzing metastatic prostate cancer patients treated with combination systemic therapy (androgen receptor signaling inhibit...
Overall, 12 and 8 randomized, controlled trials were included for systematic review and meta-analyses/network meta-analyses, respectively. In metastatic hormone-sensitive prostate cancer patients, add...
Despite aggressive clinical behavior and worse trajectory of metastatic hormone-sensitive prostate cancer and metastatic castration-resistant prostate cancer with visceral metastasis, the effectivenes...
Although aggregate data (AD) from randomised clinical trials (RCTs) are used in the majority of network meta-analyses (NMAs), other study designs (e.g., cohort studies and other non-randomised studies...
We developed the R package crossnma to perform cross-format (IPD and AD) and cross-design (RCT and NRS) NMA and network meta-regression (NMR). The models are implemented as Bayesian three-level hierar...
The R package crossnma enables the user to perform NMA and NMR with different data types in a Bayesian framework and facilitates the inclusion of all types of evidence recognising differences in risk ...
Appendicectomy remains the standard treatment for appendicitis. There is a lack of clarity on the timeframe in which surgery should be performed to avoid unfavourable outcomes....
To perform a systematic review and network meta-analysis to evaluate the impact the (1)time-of-day surgery is performed (2), time elapsed from symptom onset to hospital presentation (patient time) (3)...
A systematic review was performed as per PRISMA-NMA guidelines. The time-of-day which surgery was done was divided into day, evening and night. The other groups were divided into < 24 h, 24-48 h and >...
Sixteen studies were included with a total of 232,678 patients. The time of day at which surgery was performed had no impact on outcomes. The incidence of complicated appendicitis, post-operative comp...
Appendicectomy within 24 h of hospital admission is associated with improved outcomes compared to patients having surgery 24-48 and > 48 h after admission. The time-of-day which surgery is performed d...
Preeclampsia (PE) is a pregnancy disorder that represents a major cause of maternal and perinatal morbidity and mortality....
This network meta-analysis was registered with PROSPERO. We searched the PubMed, ClinicalTrials.gov. and Embase databases for studies published from inception to the 31...
We included eight randomized controlled trials (RCTs) involving a total of 1192 women with PE; two studies were of high quality and six were of moderate quality. Eight interventions were addressed in ...
According to the eight RCTs included in this study, Diltiazem was the most effective in reducing blood pressure in PE patients; Labetalol and Nicardipine also had good effects. Diltiazem is preferred ...
The aims of this study were to systematically review the literature and compare the relative effects of various luting agents on bonding between glass-fiber posts and root canal dentin in short- and l...
The literature was electronically searched in PubMed, Embase, and Scopus. A manual search was performed by scanning the reference lists of the included studies....
Two reviewers independently conducted the selection of studies, data extraction, and risk of bias assessment. Pairwise meta-analyses were based on random effect models. Network meta-analyses were cond...
One hundred and eighteen studies were included and assessed the effects of five luting agents. For pairwise meta-analyses, in short-term aging conditions, a significantly higher bond strength of self-...
The SARC tended to be the most effective luting agent in bonding between glass-fiber posts and root canal dentin in short- and long-term aging conditions....